{
  "version": "1.0.0",
  "last_updated": "2025-11-04",
  "description": "Universal disease-to-pathway database for hypothesis testing across 50+ diseases",
  "note": "WEIGHTS STATUS: Top 10 cancers will be populated with real TCGA frequencies by Agent Jr. Current weights are literature-based estimates (0.75 default) pending extraction. See .cursor/rules/AGENT_JR_TCGA_MUTATION_FREQUENCY_EXTRACTION.mdc for extraction plan.",
  "diseases": {
    "ovarian_cancer_hgs": {
      "full_name": "High-Grade Serous Ovarian Cancer",
      "category": "gynecologic_cancer",
      "pathways": {
        "hrd_ddr": {
          "weight": 0.95,
          "description": "Homologous recombination deficiency"
        },
        "pi3k_akt_mtor": {
          "weight": 0.9,
          "description": "PI3K/AKT/mTOR signaling"
        },
        "angiogenesis": {
          "weight": 0.85,
          "description": "VEGF-mediated angiogenesis"
        },
        "tp53": {
          "weight": 0.8,
          "description": "TP53 tumor suppressor"
        },
        "ras_mapk": {
          "weight": 0.7,
          "description": "RAS/MAPK signaling"
        }
      }
    },
    "breast_cancer": {
      "full_name": "Breast Cancer",
      "category": "breast_cancer",
      "pathways": {
        "her2_signaling": {
          "weight": 0.95,
          "description": "HER2 receptor signaling"
        },
        "er_pr_signaling": {
          "weight": 0.9,
          "description": "Estrogen/Progesterone receptors"
        },
        "pi3k_akt_mtor": {
          "weight": 0.85,
          "description": "PI3K/AKT/mTOR pathway"
        },
        "hrd_ddr": {
          "weight": 0.8,
          "description": "DNA damage response (BRCA1/2)"
        },
        "cell_cycle": {
          "weight": 0.75,
          "description": "CDK4/6 cell cycle control"
        }
      }
    },
    "lung_cancer": {
      "full_name": "Lung Cancer (NSCLC)",
      "category": "lung_cancer",
      "pathways": {
        "egfr_signaling": {
          "weight": 0.95,
          "description": "EGFR tyrosine kinase signaling"
        },
        "alk_ros1": {
          "weight": 0.9,
          "description": "ALK/ROS1 fusions"
        },
        "angiogenesis": {
          "weight": 0.85,
          "description": "VEGF angiogenesis"
        },
        "pd_l1_immune": {
          "weight": 0.8,
          "description": "PD-L1 immune checkpoint"
        },
        "kras_signaling": {
          "weight": 0.75,
          "description": "KRAS mutations"
        }
      }
    },
    "colorectal_cancer": {
      "full_name": "Colorectal Cancer",
      "category": "gi_cancer",
      "pathways": {
        "wnt_beta_catenin": {
          "weight": 0.95,
          "description": "WNT/\u03b2-catenin signaling"
        },
        "egfr_signaling": {
          "weight": 0.9,
          "description": "EGFR signaling"
        },
        "angiogenesis": {
          "weight": 0.85,
          "description": "VEGF angiogenesis"
        },
        "msi_mmr": {
          "weight": 0.8,
          "description": "Mismatch repair deficiency"
        },
        "ras_mapk": {
          "weight": 0.75,
          "description": "RAS/MAPK activation"
        }
      }
    },
    "pancreatic_cancer": {
      "full_name": "Pancreatic Ductal Adenocarcinoma",
      "category": "gi_cancer",
      "pathways": {
        "kras_signaling": {
          "weight": 0.95,
          "description": "KRAS mutations (>90%)"
        },
        "tp53": {
          "weight": 0.9,
          "description": "TP53 loss"
        },
        "smad4_tgf_beta": {
          "weight": 0.85,
          "description": "SMAD4/TGF-\u03b2 signaling"
        },
        "cdkn2a": {
          "weight": 0.8,
          "description": "CDKN2A/p16 loss"
        },
        "ddr": {
          "weight": 0.7,
          "description": "DNA damage response"
        }
      }
    },
    "prostate_cancer": {
      "full_name": "Prostate Cancer",
      "category": "genitourinary_cancer",
      "pathways": {
        "androgen_receptor": {
          "weight": 0.95,
          "description": "Androgen receptor signaling"
        },
        "pi3k_akt_pten": {
          "weight": 0.9,
          "description": "PTEN loss / PI3K activation"
        },
        "ddr": {
          "weight": 0.85,
          "description": "BRCA2 / DNA repair defects"
        },
        "tp53": {
          "weight": 0.75,
          "description": "TP53 alterations"
        },
        "tmprss2_erg": {
          "weight": 0.7,
          "description": "TMPRSS2-ERG fusion"
        }
      }
    },
    "melanoma": {
      "full_name": "Melanoma",
      "category": "skin_cancer",
      "pathways": {
        "ras_mapk_braf": {
          "weight": 0.95,
          "description": "BRAF V600E / MEK"
        },
        "pd1_immune": {
          "weight": 0.9,
          "description": "PD-1 immune checkpoint"
        },
        "kit_signaling": {
          "weight": 0.75,
          "description": "c-KIT mutations (mucosal/acral)"
        },
        "nras": {
          "weight": 0.7,
          "description": "NRAS mutations"
        },
        "cdkn2a": {
          "weight": 0.65,
          "description": "CDKN2A loss"
        }
      }
    },
    "leukemia": {
      "full_name": "Acute Myeloid Leukemia (AML)",
      "category": "hematologic_malignancy",
      "pathways": {
        "flt3_signaling": {
          "weight": 0.95,
          "description": "FLT3-ITD mutations"
        },
        "idh1_idh2": {
          "weight": 0.9,
          "description": "IDH1/2 mutations"
        },
        "npm1": {
          "weight": 0.85,
          "description": "NPM1 mutations"
        },
        "tp53": {
          "weight": 0.75,
          "description": "TP53 alterations"
        },
        "cell_differentiation": {
          "weight": 0.7,
          "description": "Differentiation blockade"
        }
      }
    },
    "multiple_myeloma": {
      "full_name": "Multiple Myeloma",
      "category": "hematologic_malignancy",
      "pathways": {
        "nfkb": {
          "weight": 0.95,
          "description": "NF-\u03baB signaling"
        },
        "proteasome": {
          "weight": 0.9,
          "description": "Proteasome degradation"
        },
        "immunomodulation": {
          "weight": 0.85,
          "description": "IMiD targets (CRBN)"
        },
        "ras_mapk": {
          "weight": 0.8,
          "description": "RAS/MAPK mutations"
        },
        "bcma_cd38": {
          "weight": 0.75,
          "description": "BCMA/CD38 antigens"
        }
      }
    },
    "glioblastoma": {
      "full_name": "Glioblastoma",
      "category": "cns_tumor",
      "pathways": {
        "egfr_signaling": {
          "weight": 0.95,
          "description": "EGFR amplification/mutation"
        },
        "pten_pi3k_akt": {
          "weight": 0.9,
          "description": "PTEN loss / PI3K activation"
        },
        "tp53_rb": {
          "weight": 0.85,
          "description": "TP53/RB pathway"
        },
        "angiogenesis": {
          "weight": 0.8,
          "description": "VEGF angiogenesis"
        },
        "idh1": {
          "weight": 0.7,
          "description": "IDH1 mutations (secondary GBM)"
        }
      }
    },
    "renal_cell_carcinoma": {
      "full_name": "Renal Cell Carcinoma (Clear Cell)",
      "category": "genitourinary_cancer",
      "pathways": {
        "vhl_hif": {
          "weight": 0.95,
          "description": "VHL loss / HIF stabilization"
        },
        "angiogenesis": {
          "weight": 0.9,
          "description": "VEGF/PDGF angiogenesis"
        },
        "mtor": {
          "weight": 0.85,
          "description": "mTOR signaling"
        },
        "immune_checkpoint": {
          "weight": 0.8,
          "description": "PD-1/PD-L1"
        },
        "chromatin_remodeling": {
          "weight": 0.7,
          "description": "PBRM1/BAP1/SETD2"
        }
      }
    },
    "gastric_cancer": {
      "full_name": "Gastric Cancer",
      "category": "gi_cancer",
      "pathways": {
        "her2_signaling": {
          "weight": 0.9,
          "description": "HER2 amplification"
        },
        "vegf_angiogenesis": {
          "weight": 0.85,
          "description": "VEGF-mediated angiogenesis"
        },
        "tp53": {
          "weight": 0.8,
          "description": "TP53 mutations"
        },
        "msi": {
          "weight": 0.75,
          "description": "Microsatellite instability"
        },
        "ebv": {
          "weight": 0.7,
          "description": "EBV-associated (PD-L1)"
        }
      }
    },
    "hepatocellular_carcinoma": {
      "full_name": "Hepatocellular Carcinoma",
      "category": "gi_cancer",
      "pathways": {
        "angiogenesis": {
          "weight": 0.95,
          "description": "VEGF/PDGF angiogenesis"
        },
        "wnt_beta_catenin": {
          "weight": 0.85,
          "description": "WNT/\u03b2-catenin (CTNNB1)"
        },
        "tp53": {
          "weight": 0.8,
          "description": "TP53 mutations"
        },
        "tert": {
          "weight": 0.75,
          "description": "TERT promoter mutations"
        },
        "immune_checkpoint": {
          "weight": 0.7,
          "description": "PD-1/PD-L1"
        }
      }
    },
    "endometrial_cancer": {
      "full_name": "Endometrial Cancer",
      "category": "gynecologic_cancer",
      "pathways": {
        "pten_pi3k_akt": {
          "weight": 0.95,
          "description": "PTEN loss / PI3K activation"
        },
        "msi_mmr": {
          "weight": 0.9,
          "description": "Mismatch repair deficiency"
        },
        "tp53": {
          "weight": 0.8,
          "description": "TP53 mutations (serous type)"
        },
        "wnt_beta_catenin": {
          "weight": 0.75,
          "description": "CTNNB1 mutations"
        },
        "fgfr": {
          "weight": 0.7,
          "description": "FGFR2 mutations"
        }
      }
    },
    "bladder_cancer": {
      "full_name": "Bladder Cancer (Urothelial)",
      "category": "genitourinary_cancer",
      "pathways": {
        "fgfr": {
          "weight": 0.9,
          "description": "FGFR3 mutations/fusions"
        },
        "tp53_rb": {
          "weight": 0.85,
          "description": "TP53/RB pathway"
        },
        "immune_checkpoint": {
          "weight": 0.8,
          "description": "PD-L1 expression"
        },
        "erbb2": {
          "weight": 0.75,
          "description": "ERBB2 (HER2) alterations"
        },
        "pi3k_akt": {
          "weight": 0.7,
          "description": "PIK3CA mutations"
        }
      }
    },
    "esophageal_cancer": {
      "full_name": "Esophageal Cancer (Adenocarcinoma)",
      "category": "gi_cancer",
      "pathways": {
        "her2_signaling": {
          "weight": 0.9,
          "description": "HER2 amplification"
        },
        "angiogenesis": {
          "weight": 0.85,
          "description": "VEGF angiogenesis"
        },
        "tp53": {
          "weight": 0.8,
          "description": "TP53 mutations"
        },
        "cdkn2a": {
          "weight": 0.75,
          "description": "CDKN2A loss"
        },
        "pi3k_akt": {
          "weight": 0.7,
          "description": "PIK3CA/PTEN"
        }
      }
    },
    "cervical_cancer": {
      "full_name": "Cervical Cancer",
      "category": "gynecologic_cancer",
      "pathways": {
        "hpv_e6_e7": {
          "weight": 0.95,
          "description": "HPV E6/E7 (TP53/RB inactivation)"
        },
        "pi3k_akt": {
          "weight": 0.85,
          "description": "PIK3CA mutations"
        },
        "immune_checkpoint": {
          "weight": 0.8,
          "description": "PD-1/PD-L1"
        },
        "angiogenesis": {
          "weight": 0.75,
          "description": "VEGF"
        },
        "erbb": {
          "weight": 0.65,
          "description": "ERBB2/3"
        }
      }
    },
    "thyroid_cancer": {
      "full_name": "Thyroid Cancer (Papillary)",
      "category": "endocrine_tumor",
      "pathways": {
        "braf_mapk": {
          "weight": 0.95,
          "description": "BRAF V600E"
        },
        "ras_signaling": {
          "weight": 0.85,
          "description": "RAS mutations"
        },
        "ret_fusion": {
          "weight": 0.8,
          "description": "RET/PTC fusions"
        },
        "vegf_angiogenesis": {
          "weight": 0.7,
          "description": "VEGF pathway"
        },
        "pi3k_akt": {
          "weight": 0.65,
          "description": "PIK3CA/PTEN"
        }
      }
    },
    "sarcoma": {
      "full_name": "Soft Tissue Sarcoma",
      "category": "mesenchymal_tumor",
      "pathways": {
        "tp53_rb": {
          "weight": 0.85,
          "description": "TP53/RB alterations"
        },
        "angiogenesis": {
          "weight": 0.8,
          "description": "VEGF"
        },
        "kit_pdgfr": {
          "weight": 0.75,
          "description": "c-KIT/PDGFR (GIST)"
        },
        "mdm2_cdk4": {
          "weight": 0.7,
          "description": "MDM2/CDK4 amplification"
        },
        "chromatin_remodeling": {
          "weight": 0.65,
          "description": "SWI/SNF complex"
        }
      }
    },
    "nhl_dlbcl": {
      "full_name": "Diffuse Large B-Cell Lymphoma",
      "category": "hematologic_malignancy",
      "pathways": {
        "bcr_signaling": {
          "weight": 0.95,
          "description": "B-cell receptor signaling"
        },
        "nfkb": {
          "weight": 0.9,
          "description": "NF-\u03baB activation"
        },
        "bcl2": {
          "weight": 0.85,
          "description": "BCL2 overexpression"
        },
        "tp53": {
          "weight": 0.75,
          "description": "TP53 mutations"
        },
        "myd88": {
          "weight": 0.7,
          "description": "MYD88 L265P"
        }
      }
    },
    "cll": {
      "full_name": "Chronic Lymphocytic Leukemia",
      "category": "hematologic_malignancy",
      "pathways": {
        "btk_signaling": {
          "weight": 0.95,
          "description": "BTK (Bruton's tyrosine kinase)"
        },
        "bcl2": {
          "weight": 0.9,
          "description": "BCL2 overexpression"
        },
        "tp53_atm": {
          "weight": 0.85,
          "description": "TP53/ATM deletions"
        },
        "bcr_signaling": {
          "weight": 0.8,
          "description": "B-cell receptor signaling"
        },
        "notch1": {
          "weight": 0.7,
          "description": "NOTCH1 mutations"
        }
      }
    },
    "hodgkin_lymphoma": {
      "full_name": "Hodgkin Lymphoma",
      "category": "hematologic_malignancy",
      "pathways": {
        "pd1_immune": {
          "weight": 0.95,
          "description": "PD-1 checkpoint (9p24.1 amplification)"
        },
        "nfkb": {
          "weight": 0.85,
          "description": "NF-\u03baB activation"
        },
        "jak_stat": {
          "weight": 0.8,
          "description": "JAK/STAT signaling"
        },
        "ebv": {
          "weight": 0.7,
          "description": "EBV-associated"
        },
        "cd30": {
          "weight": 0.9,
          "description": "CD30 antigen"
        }
      }
    },
    "mds": {
      "full_name": "Myelodysplastic Syndromes",
      "category": "hematologic_malignancy",
      "pathways": {
        "splicing": {
          "weight": 0.95,
          "description": "SF3B1/SRSF2/U2AF1 mutations"
        },
        "epigenetics": {
          "weight": 0.9,
          "description": "TET2/DNMT3A/ASXL1"
        },
        "tp53": {
          "weight": 0.8,
          "description": "TP53 mutations"
        },
        "ras_signaling": {
          "weight": 0.7,
          "description": "NRAS/KRAS"
        },
        "erythropoiesis": {
          "weight": 0.75,
          "description": "Erythroid differentiation"
        }
      }
    },
    "cml": {
      "full_name": "Chronic Myeloid Leukemia",
      "category": "hematologic_malignancy",
      "pathways": {
        "bcr_abl1": {
          "weight": 0.98,
          "description": "BCR-ABL1 fusion (Philadelphia chromosome)"
        },
        "tki_resistance": {
          "weight": 0.85,
          "description": "T315I and other TKI resistance mutations"
        },
        "jak_stat": {
          "weight": 0.7,
          "description": "JAK/STAT signaling"
        },
        "pi3k_akt": {
          "weight": 0.65,
          "description": "PI3K/AKT pathway"
        },
        "src_family": {
          "weight": 0.6,
          "description": "SRC family kinases"
        }
      }
    },
    "mesothelioma": {
      "full_name": "Malignant Pleural Mesothelioma",
      "category": "thoracic_cancer",
      "pathways": {
        "bap1": {
          "weight": 0.95,
          "description": "BAP1 loss"
        },
        "nf2_hippo": {
          "weight": 0.9,
          "description": "NF2 / Hippo pathway"
        },
        "cdkn2a": {
          "weight": 0.85,
          "description": "CDKN2A deletion"
        },
        "immune_checkpoint": {
          "weight": 0.75,
          "description": "PD-L1"
        },
        "angiogenesis": {
          "weight": 0.7,
          "description": "VEGF"
        }
      }
    },
    "cholangiocarcinoma": {
      "full_name": "Cholangiocarcinoma",
      "category": "gi_cancer",
      "pathways": {
        "fgfr": {
          "weight": 0.9,
          "description": "FGFR2 fusions"
        },
        "idh1": {
          "weight": 0.85,
          "description": "IDH1 mutations"
        },
        "tp53_kras": {
          "weight": 0.8,
          "description": "TP53/KRAS"
        },
        "her2": {
          "weight": 0.7,
          "description": "ERBB2 amplification"
        },
        "bap1": {
          "weight": 0.65,
          "description": "BAP1 mutations"
        }
      }
    },
    "neuroendocrine_tumor": {
      "full_name": "Neuroendocrine Tumor (GI/Lung)",
      "category": "neuroendocrine",
      "pathways": {
        "men1": {
          "weight": 0.85,
          "description": "MEN1 mutations"
        },
        "daxx_atrx": {
          "weight": 0.8,
          "description": "DAXX/ATRX alterations"
        },
        "mtor": {
          "weight": 0.75,
          "description": "mTOR pathway"
        },
        "somatostatin": {
          "weight": 0.9,
          "description": "Somatostatin receptor"
        },
        "chromatin_remodeling": {
          "weight": 0.7,
          "description": "Chromatin modifiers"
        }
      }
    },
    "alzheimers": {
      "full_name": "Alzheimer's Disease",
      "category": "neurodegenerative",
      "pathways": {
        "amyloid_beta": {
          "weight": 0.95,
          "description": "Amyloid-\u03b2 accumulation"
        },
        "tau_protein": {
          "weight": 0.9,
          "description": "Tau hyperphosphorylation"
        },
        "neuroinflammation": {
          "weight": 0.85,
          "description": "Microglial activation"
        },
        "apoe4": {
          "weight": 0.8,
          "description": "APOE4 genetic risk"
        },
        "oxidative_stress": {
          "weight": 0.75,
          "description": "Mitochondrial dysfunction"
        }
      }
    },
    "parkinsons": {
      "full_name": "Parkinson's Disease",
      "category": "neurodegenerative",
      "pathways": {
        "alpha_synuclein": {
          "weight": 0.95,
          "description": "\u03b1-synuclein aggregation"
        },
        "mitochondrial_dysfunction": {
          "weight": 0.9,
          "description": "Complex I deficiency"
        },
        "dopamine_signaling": {
          "weight": 0.85,
          "description": "Dopaminergic neuron loss"
        },
        "lrrk2": {
          "weight": 0.75,
          "description": "LRRK2 mutations"
        },
        "gba": {
          "weight": 0.7,
          "description": "GBA (glucocerebrosidase) deficiency"
        }
      }
    },
    "rheumatoid_arthritis": {
      "full_name": "Rheumatoid Arthritis",
      "category": "autoimmune",
      "pathways": {
        "tnf_alpha": {
          "weight": 0.95,
          "description": "TNF-\u03b1 inflammation"
        },
        "il6": {
          "weight": 0.9,
          "description": "IL-6 signaling"
        },
        "jak_stat": {
          "weight": 0.85,
          "description": "JAK/STAT pathway"
        },
        "b_cell": {
          "weight": 0.8,
          "description": "B-cell activation"
        },
        "t_cell": {
          "weight": 0.75,
          "description": "T-cell co-stimulation"
        }
      }
    },
    "type_2_diabetes": {
      "full_name": "Type 2 Diabetes",
      "category": "metabolic",
      "pathways": {
        "insulin_resistance": {
          "weight": 0.95,
          "description": "Insulin receptor signaling"
        },
        "beta_cell_dysfunction": {
          "weight": 0.9,
          "description": "Pancreatic \u03b2-cell failure"
        },
        "inflammation": {
          "weight": 0.8,
          "description": "Chronic inflammation"
        },
        "lipid_metabolism": {
          "weight": 0.75,
          "description": "Dyslipidemia"
        },
        "glp1": {
          "weight": 0.85,
          "description": "GLP-1 signaling"
        }
      }
    },
    "atherosclerosis": {
      "full_name": "Atherosclerosis",
      "category": "cardiovascular",
      "pathways": {
        "ldl_cholesterol": {
          "weight": 0.95,
          "description": "LDL oxidation"
        },
        "endothelial_dysfunction": {
          "weight": 0.9,
          "description": "Endothelial injury"
        },
        "inflammation": {
          "weight": 0.85,
          "description": "Chronic vascular inflammation"
        },
        "pcsk9": {
          "weight": 0.8,
          "description": "PCSK9 / LDL receptor regulation"
        },
        "foam_cell_formation": {
          "weight": 0.75,
          "description": "Macrophage foam cells"
        }
      }
    },
    "psoriasis": {
      "full_name": "Psoriasis",
      "category": "autoimmune",
      "pathways": {
        "il23_il17": {
          "weight": 0.95,
          "description": "IL-23/IL-17 axis"
        },
        "tnf_alpha": {
          "weight": 0.85,
          "description": "TNF-\u03b1 signaling"
        },
        "keratinocyte_proliferation": {
          "weight": 0.8,
          "description": "Hyperproliferation"
        },
        "t_cell": {
          "weight": 0.75,
          "description": "T-cell activation"
        },
        "nfkb": {
          "weight": 0.7,
          "description": "NF-\u03baB signaling"
        }
      }
    },
    "crohns_disease": {
      "full_name": "Crohn's Disease",
      "category": "inflammatory_bowel",
      "pathways": {
        "tnf_alpha": {
          "weight": 0.95,
          "description": "TNF-\u03b1 inflammation"
        },
        "il23": {
          "weight": 0.9,
          "description": "IL-23 signaling"
        },
        "gut_barrier": {
          "weight": 0.85,
          "description": "Intestinal barrier dysfunction"
        },
        "t_cell": {
          "weight": 0.8,
          "description": "T-cell dysregulation"
        },
        "jak_stat": {
          "weight": 0.75,
          "description": "JAK/STAT signaling"
        }
      }
    },
    "ulcerative_colitis": {
      "full_name": "Ulcerative Colitis",
      "category": "inflammatory_bowel",
      "pathways": {
        "tnf_alpha": {
          "weight": 0.95,
          "description": "TNF-\u03b1 inflammation"
        },
        "il23": {
          "weight": 0.85,
          "description": "IL-23 signaling"
        },
        "gut_barrier": {
          "weight": 0.8,
          "description": "Mucosal barrier"
        },
        "jak_stat": {
          "weight": 0.75,
          "description": "JAK/STAT signaling"
        },
        "oxidative_stress": {
          "weight": 0.7,
          "description": "ROS production"
        }
      }
    },
    "macular_degeneration": {
      "full_name": "Age-Related Macular Degeneration",
      "category": "ophthalmologic",
      "pathways": {
        "angiogenesis": {
          "weight": 0.95,
          "description": "VEGF-mediated neovascularization"
        },
        "complement": {
          "weight": 0.85,
          "description": "Complement system (CFH)"
        },
        "oxidative_stress": {
          "weight": 0.8,
          "description": "Retinal oxidative damage"
        },
        "inflammation": {
          "weight": 0.75,
          "description": "Chronic inflammation"
        },
        "lipofuscin": {
          "weight": 0.7,
          "description": "Lipofuscin accumulation (drusen)"
        }
      }
    },
    "copd": {
      "full_name": "Chronic Obstructive Pulmonary Disease",
      "category": "respiratory",
      "pathways": {
        "inflammation": {
          "weight": 0.95,
          "description": "Neutrophilic inflammation"
        },
        "protease_antiprotease": {
          "weight": 0.9,
          "description": "Elastase / \u03b11-antitrypsin imbalance"
        },
        "oxidative_stress": {
          "weight": 0.85,
          "description": "ROS from smoking"
        },
        "fibrosis": {
          "weight": 0.75,
          "description": "Small airway remodeling"
        },
        "apoptosis": {
          "weight": 0.7,
          "description": "Alveolar cell death"
        }
      }
    },
    "asthma": {
      "full_name": "Asthma",
      "category": "respiratory",
      "pathways": {
        "il4_il13": {
          "weight": 0.95,
          "description": "IL-4/IL-13 (Type 2 inflammation)"
        },
        "ige": {
          "weight": 0.9,
          "description": "IgE-mediated allergic response"
        },
        "eosinophils": {
          "weight": 0.85,
          "description": "Eosinophilic inflammation"
        },
        "smooth_muscle": {
          "weight": 0.8,
          "description": "Airway smooth muscle constriction"
        },
        "leukotriene": {
          "weight": 0.75,
          "description": "Leukotriene signaling"
        }
      }
    },
    "pulmonary_fibrosis": {
      "full_name": "Idiopathic Pulmonary Fibrosis",
      "category": "respiratory",
      "pathways": {
        "tgf_beta": {
          "weight": 0.95,
          "description": "TGF-\u03b2 fibrotic signaling"
        },
        "fibroblast_activation": {
          "weight": 0.9,
          "description": "Myofibroblast differentiation"
        },
        "oxidative_stress": {
          "weight": 0.8,
          "description": "Oxidative injury"
        },
        "epithelial_injury": {
          "weight": 0.75,
          "description": "Alveolar epithelial damage"
        },
        "senescence": {
          "weight": 0.7,
          "description": "Cellular senescence"
        }
      }
    },
    "endometriosis": {
      "full_name": "Endometriosis",
      "category": "gynecologic_benign",
      "pathways": {
        "estrogen_signaling": {
          "weight": 0.95,
          "description": "Estrogen-dependent growth"
        },
        "inflammation": {
          "weight": 0.9,
          "description": "Chronic pelvic inflammation"
        },
        "angiogenesis": {
          "weight": 0.85,
          "description": "VEGF-mediated neovascularization"
        },
        "immune_dysfunction": {
          "weight": 0.75,
          "description": "Impaired immune clearance"
        },
        "nerve_growth": {
          "weight": 0.7,
          "description": "Neurogenesis (pain)"
        }
      }
    },
    "polycystic_ovary_syndrome": {
      "full_name": "Polycystic Ovary Syndrome (PCOS)",
      "category": "endocrine",
      "pathways": {
        "insulin_resistance": {
          "weight": 0.95,
          "description": "Hyperinsulinemia"
        },
        "androgen_excess": {
          "weight": 0.9,
          "description": "Hyperandrogenism"
        },
        "lh_fsh_imbalance": {
          "weight": 0.85,
          "description": "LH/FSH ratio dysregulation"
        },
        "inflammation": {
          "weight": 0.75,
          "description": "Chronic low-grade inflammation"
        },
        "oxidative_stress": {
          "weight": 0.7,
          "description": "ROS production"
        }
      }
    },
    "osteoporosis": {
      "full_name": "Osteoporosis",
      "category": "bone_metabolic",
      "pathways": {
        "osteoclast_activity": {
          "weight": 0.95,
          "description": "RANKL/RANK signaling"
        },
        "estrogen_deficiency": {
          "weight": 0.9,
          "description": "Postmenopausal estrogen loss"
        },
        "calcium_vitamin_d": {
          "weight": 0.85,
          "description": "Calcium/Vitamin D homeostasis"
        },
        "wnt_signaling": {
          "weight": 0.75,
          "description": "WNT/LRP5 osteoblast regulation"
        },
        "sclerostin": {
          "weight": 0.7,
          "description": "Sclerostin inhibition"
        }
      }
    },
    "migraine": {
      "full_name": "Migraine",
      "category": "neurological",
      "pathways": {
        "cgrp": {
          "weight": 0.95,
          "description": "Calcitonin gene-related peptide (CGRP)"
        },
        "serotonin": {
          "weight": 0.85,
          "description": "5-HT receptor signaling"
        },
        "cortical_spreading_depression": {
          "weight": 0.8,
          "description": "Neuronal wave depolarization"
        },
        "inflammation": {
          "weight": 0.75,
          "description": "Neurogenic inflammation"
        },
        "vascular": {
          "weight": 0.7,
          "description": "Vasodilation/constriction"
        }
      }
    },
    "epilepsy": {
      "full_name": "Epilepsy",
      "category": "neurological",
      "pathways": {
        "gaba_glutamate": {
          "weight": 0.95,
          "description": "Excitatory/inhibitory imbalance"
        },
        "ion_channels": {
          "weight": 0.9,
          "description": "Sodium/potassium channel dysfunction"
        },
        "scn1a": {
          "weight": 0.8,
          "description": "SCN1A mutations (Dravet syndrome)"
        },
        "neuroinflammation": {
          "weight": 0.7,
          "description": "Chronic inflammation"
        },
        "mitochondrial": {
          "weight": 0.65,
          "description": "Mitochondrial dysfunction"
        }
      }
    },
    "multiple_sclerosis": {
      "full_name": "Multiple Sclerosis",
      "category": "autoimmune_neurological",
      "pathways": {
        "t_cell_autoreactivity": {
          "weight": 0.95,
          "description": "Autoreactive T-cells"
        },
        "b_cell": {
          "weight": 0.9,
          "description": "B-cell antibody production"
        },
        "demyelination": {
          "weight": 0.85,
          "description": "Oligodendrocyte damage"
        },
        "inflammation": {
          "weight": 0.8,
          "description": "CNS inflammation"
        },
        "blood_brain_barrier": {
          "weight": 0.75,
          "description": "BBB breakdown"
        }
      }
    },
    "systemic_lupus": {
      "full_name": "Systemic Lupus Erythematosus (SLE)",
      "category": "autoimmune",
      "pathways": {
        "interferon": {
          "weight": 0.95,
          "description": "Type I interferon signature"
        },
        "b_cell": {
          "weight": 0.9,
          "description": "B-cell hyperactivity (autoantibodies)"
        },
        "complement": {
          "weight": 0.85,
          "description": "Complement activation"
        },
        "immune_complex": {
          "weight": 0.8,
          "description": "Immune complex deposition"
        },
        "t_cell": {
          "weight": 0.75,
          "description": "T-cell dysregulation"
        }
      }
    },
    "ckd": {
      "full_name": "Chronic Kidney Disease",
      "category": "renal",
      "pathways": {
        "fibrosis": {
          "weight": 0.95,
          "description": "Renal fibrosis (TGF-\u03b2)"
        },
        "inflammation": {
          "weight": 0.85,
          "description": "Chronic inflammation"
        },
        "oxidative_stress": {
          "weight": 0.8,
          "description": "ROS production"
        },
        "raas": {
          "weight": 0.9,
          "description": "Renin-angiotensin-aldosterone system"
        },
        "anemia": {
          "weight": 0.7,
          "description": "Erythropoietin deficiency"
        }
      }
    },
    "nafld": {
      "full_name": "Non-Alcoholic Fatty Liver Disease",
      "category": "hepatic_metabolic",
      "pathways": {
        "insulin_resistance": {
          "weight": 0.95,
          "description": "Hepatic insulin resistance"
        },
        "lipotoxicity": {
          "weight": 0.9,
          "description": "Free fatty acid accumulation"
        },
        "inflammation": {
          "weight": 0.85,
          "description": "NASH inflammation"
        },
        "fibrosis": {
          "weight": 0.75,
          "description": "Hepatic stellate cell activation"
        },
        "oxidative_stress": {
          "weight": 0.8,
          "description": "ROS / lipid peroxidation"
        }
      }
    }
  },
  "pathway_descriptions": {
    "hrd_ddr": "Homologous recombination deficiency and DNA damage response",
    "pi3k_akt_mtor": "PI3K/AKT/mTOR signaling pathway",
    "angiogenesis": "VEGF-mediated blood vessel formation",
    "tp53": "TP53 tumor suppressor pathway",
    "ras_mapk": "RAS/RAF/MEK/ERK signaling cascade",
    "her2_signaling": "HER2 (ERBB2) receptor tyrosine kinase signaling",
    "egfr_signaling": "EGFR receptor tyrosine kinase signaling",
    "immune_checkpoint": "PD-1/PD-L1/CTLA-4 immune checkpoints",
    "wnt_beta_catenin": "WNT/\u03b2-catenin canonical signaling",
    "nfkb": "NF-\u03baB transcription factor signaling"
  }
}